API Holdings Ltd, the parent company of PharmEasy, is one of India’s leading digital healthcare platforms offering services in diagnostics, telemedicine, and medicine delivery. The company has previously filed DRHP (Draft Red Herring Prospectus) with SEBI and is expected to go public in the near future.

Investors can gain exposure to this rapidly growing sector by participating in its unlisted equity. With a strong presence in India’s digital health ecosystem, PharmEasy aims to disrupt traditional healthcare delivery models by improving accessibility and affordability of medical services.